BIOCRYST PHARMACEUTICALS, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2016
Total Assets: $89.8M
Liabilities Breakdown FY2016
Total Liabilities: $88.3M
Asset Breakdown
Total Assets: $89.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $22.1M | 24.6% |
| Accounts Receivable | $8.8M | 9.8% |
| Inventory | $500.0K | 0.6% |
| Property, Plant & Equipment | $9.9M | 11.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $48.6M | 54.0% |
Liabilities Breakdown
Total Liabilities: $88.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.3M | 4.8% |
| Long-Term Debt | $23.0M | 26.1% |
| Other Liabilities | $61.0M | 69.1% |